BRICANYL

This brand name is authorized in Australia, Austria, Brazil, Canada, Estonia, Finland, France, Hong Kong SAR China, Ireland, Japan, Malta, Netherlands, New Zealand, Tunisia, Turkey, UK.

Active ingredients

The drug BRICANYL contains one active pharmaceutical ingredient (API):

1
UNII 576PU70Y8E - TERBUTALINE SULFATE
 

Terbutaline is a selective beta2-adrenoceptor agonist, thus producing relaxation of bronchial smooth muscle, inhibition of the release of endogenous spasmogens, inhibitions of oedema caused by endogenous mediators, increased mucociliary clearance and relaxation of the uterine muscle.

 
Read more about Terbutaline

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 BRICANYL Tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 BRICANYL Solution for injection or infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 BRICANYL TURBOHALER Inhalation powder MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03AC03 Terbutaline R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC03
R03CC03 Terbutaline R Respiratory system → R03 Drugs for obstructive airway diseases → R03C Adrenergics for systemic use → R03CC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03CC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 1034K, 12267P, 2817G
BR Câmara de Regulação do Mercado de Medicamentos 502300801139315, 502300901133319
CA Health Products and Food Branch 00786616
EE Ravimiamet 1225145, 1628793, 1734724, 1751026, 1781906
FI Lääkealan turvallisuus- ja kehittämiskeskus 068001, 379698
FR Base de données publique des médicaments 60961427, 62600742, 68242177
GB Medicines & Healthcare Products Regulatory Agency 138379, 26851, 26858, 28294, 299801, 36340, 365069, 375768, 377581, 393592
HK Department of Health Drug Office 19618, 30992
IE Health Products Regulatory Authority 15458, 37420, 76408
JP 医薬品医療機器総合機構 2252003F1085, 2252003Q1035, 2252401A1030
MT Medicines Authority AA227/00903
NL Z-Index G-Standaard 13777785, 15685586
NL Z-Index G-Standaard, PRK 152013, 152021
NZ Medicines and Medical Devices Safety Authority 1302
TN Direction de la Pharmacie et du Médicament 5100012, 5100016, 5100017H, 5100018, 5100019
TR İlaç ve Tıbbi Cihaz Kurumu 8699786010406

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.